Top 20 Biotechnology VC Funds & Investors in Hungary (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Delin Ventures
VC Fund
|
4 | United Kingdom, Germany, Hungary | Seed, Series A, Series B | Software, Biotechnology, Information Technology | $1.3M–$100M |
|
FastVentures
VC Fund
|
4 | Hungary, South Korea, United States | Seed, Series A, Series B | Software, Biotechnology, Information Technology | $424k–$31M |
|
Atlantic
VC Fund
|
3 | Germany, Switzerland, United States | Seed, Pre-Seed, Series A | Software, Health Care, Financial Services | $850k–$32M |
|
Accel
VC Fund
|
3 | United States, India, United Kingdom | Series A, Series B, Seed | Software, SaaS, Information Technology | $1.5M–$70M |
|
XTX Ventures
VC Fund
|
3 | United Kingdom, United States, Israel | Series A, Seed | Artificial Intelligence, Software, Machine Learning | $1.4M–$24M |
|
O2h Ventures
VC Fund
|
3 | United Kingdom, Hungary | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $655k–$26M |
|
The Vascular Group
VC Fund
|
2 | Hungary | Series A | Medical, Health Care, Biotechnology | |
|
Euroventures
VC Fund
|
2 | Hungary, United States, United Kingdom | Series A, Seed | Software, Information Technology, E-Commerce | $531k–$11M |
|
Bonitás Ventures
VC Fund
|
2 | Hungary | Seed, Series A | Information Technology, Software, Education | $241k–$4.4M |
|
Boston Millennia Partners
VC Fund
|
2 | United States, Israel, Hungary | Series C, Series B | Health Care, Biotechnology, Software | $5M–$53M |
|
Portfolion
VC Fund
|
2 | Hungary, Poland, United States | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $439k–$94M |
|
European Commission
VC Fund
|
1 | France, Spain, United Kingdom | Grant, Seed, Pre-Seed | Software, Health Care, Biotechnology | $55k–$36M |
|
Széchenyi Capital Fund Management
VC Fund
|
1 | Hungary | Series A | Fashion, Medical, Shopping | |
|
Mercia Fund Managers
VC Fund
|
1 | United Kingdom, United States, Hungary | Seed, Series A | Software, Health Care, Biotechnology | $196k–$14M |
|
Merck Global Health Innovation Fund
VC Fund
|
1 | United States, Canada, United Kingdom | Series B, Series A | Health Care, Biotechnology, Information Technology | $9.3M–$98M |
|
Texas HALO Fund
VC Fund
|
1 | United States, Canada, Hungary | Seed, Convertible Note, Series A | Health Care, Medical Device, Software | $105k–$10M |
|
Societe Generale Asset Management
VC Fund
|
1 | France, United States, Germany | Series B, Series A | Biotechnology, Software, Health Care | $1.9M–$55M |
|
Day One Capital
VC Fund
|
1 | Hungary, United States, Croatia | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $310k–$35M |
|
Fast Ventures
VC Fund
|
1 | South Korea, Hungary, United States | Seed, Series A, Pre-Seed | Apps, Health Care, E-Commerce | $111k–$6.9M |
|
MassMutual Ventures
VC Fund
|
1 | United States, India, Singapore | Series A, Series B, Seed | Software, Financial Services, Information Technology | $2.5M–$40M |
| Access all 29 VC funds in Hungary Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We are partnering with remarkable entrepreneurs and scientists on the mission of our lives: elevating humanity.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Germany, Hungary
Investor stats
- Total investments: 31
- Round size: Seed $1.3M–$9.2M; Series A $5.1M–$30M; Series B $15M–$100M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Turbine — Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.
- Penzilla — At Penzilla, we believe it's time to make corporate pension provision the way it really should be - simple. That's why we offer a solution that helps everyone get the maximum benefit from corporate pension options. Most importantly, we enable every employer to achieve true corporate social responsibility with 100% compliance and everyemployee to receive a fair pension. This is how corporate pension provision works with Penzilla: Let's "Simply Provision" together.
- Swarm Oncology — Swarm Oncology is a biotechnology company that develops novel T cell therapies for cancer patients.
venture capital
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Hungary, South Korea, United States
Investor stats
- Total investments: 26
- Round size: Seed $424k–$31M; Series A $1.3M–$2.3M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
- NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Software, Health Care, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 194
- Round size: Seed $1.2M–$9.1M; Pre-Seed $850k–$3.8M; Series A $4.6M–$32M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Cluno — Cluno is an online car subscription service providing rental cars irrespective of any contracts. Cluno's digital car subscription challenges traditional car ownership models in the mobility market and expands the space between hourly and years-long commitments with a flexible option and transparent, fully predictable costs. The carsubscription is offered at a monthly package price, which covers almost all car-related costs such as maintenance, wear and tear, seasonal tires, warranty, registration, vehicle tax, insurance, and vehicle inspections. The minimum booking period is six months per vehicle. Subject to a notice period of three months, customers can change their vehicle after the minimum period, pause their car subscription, or continue on with their Cluno car indefinitely.
- bonify — Bonify, a Berlin based FinTech-Start-up, enables customers to benefit from their credit scoring and financial data. The company gives customers free and easy access to their credit score and let them upload additional relevant data. Then, it offers tools and personalized recommendations to help optimize the customer’s financial situation.Foundedin 2015 by key executives of McKinsey and Zalando, bonify has received significant funding from internationally leading VCs and successful entrepreneurs.
- tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
First partner to exceptional teams everywhere
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1836
- Round size: Seed $1.5M–$10M; Series A $4.4M–$40M; Series B $9.5M–$70M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $14M in 2019
Portfolio highlights
- Solda.AI — Fully automated sales departments for b2c
- Higgsfield — The ultimate AI-powered camera control for creators by creators
- Dovetail — Make sense of all kinds of customer research in one intuitive, collaborative, and searchable research repository.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Seed
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 75
- Round size: Seed $1.4M–$7.6M; Series A $3.8M–$24M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- QMatter — QMatter develops simulation tools for molecular modelling based on quantum compression mechanism.
- SPhotonix — SPhotonix has developed the world's first 3D Memory Crystal capable of storing up to 360 TB data and producing state-of-the-art optical devices. The memory crystal is both durable and sustainable using ground-breaking nano-etching technology for data storage that can last thousands of years. Its optical device fabrication possibilities includeimaging, microscopy, sensing and telecommunication. Watch our story: https://www.youtube.com/watch?v=003WzGDBd54
- Ethos — Ethos is an AI-driven platform that matches individuals with opportunities. It uses AI to scan hundreds of millions of profiles and match clients with the most relevant experts for insight-driven calls. The platform streamlines the entire process from booking to communication and compensation, making it equitable for clients and experts. Whilecurrently focused on expert calls, Ethos is expanding to match advisors with startups, speakers with events, and talent with employers.
Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 39
- Round size: Seed $655k–$7.9M; Series A $1.9M–$26M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Neurocentrx — Neurocentrx is a specialty pharma company, developing and in-licensing products in pain, palliative care, psychiatry and mood disorders.
- Alevin Therapeutics — Our mission is to develop safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies
The Vascular Group is a medical practice company that delivers art diagnostic and therapeutic procedures.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A
- Geography: Hungary
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VRG Therapeutics — VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.
- Novamigra Therapeutics — Cutting-edge medical care at Agape with Framer template, where AI technology meets compassionate service. Experience personalized treatment and innovative solutions for your health needs.
Budapest-based Euroventures is one of the longest-established and leading independent private equity and venture capital firms in Central Europe, with a proven ability to achieve international exits over two decades in a fast-changing environment. It has advised or is advising five investment programmes totalling over €180m since 1989, with a focuson funding INNOVATION and GROWTH in Hungary and Central Europe. The investors in Euroventures funds have been international institutional Investors. Euroventures' nearly 50 current and former portfolio companies illustrate the commitment to provide steady support through the cycles of the regional and global economy. Its professional team members have many decades of private equity / venture capital experience between them. Recent investments have targeted growing businesses with innovative technologies in the fields of medtech, big data, security, and IoT among others. Euroventures has had an outstanding track record in supporting its portfolio companies entering global markets. As a result, it has delivered highly successful exits, including IPOs (Vienna, NASDAQ, NYSE) and several dozens of trade sales to international corporations. Euroventures is a founding member of the Hungarian Venture Capital Association and complies with the conduct, governing principles and valuation/reporting guidelines of Invest Europe.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Series A, Seed
- Geography: Hungary, United States, United Kingdom
Investor stats
- Total investments: 28
- Round size: Seed $531k–$2.5M; Series A $531k–$11M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Datapao — Discover DATAPAO's data consulting solutions in cloud migrations, data science, data engineering, AI & ML.
- Daytrip — Daytrip is a platform for traveling with local drivers. It allows independent travelers to get the most out of their vacation by connecting them to local drivers, who drive them from one city to another with their own cars, discovering local sights and culture on the way.It gives travelers an opportunity to see otherwise unreachable countrysidesights, meet real locals and get to know local history, culture and current affairs first-hand. Daytrip is an entirely new approach to traveling, combining the comfort of package holidays with the flexibility of independent planning and authenticity of backpacking.
- Hypefy — An influencer marketing platform built for brands that want to discover creators, run campaigns, and measure performance with ease.
Bonitás is more than an investor. Our team helps the brave founders to pursue their dreams and build extraordinary companies. We push because we respect. Partnering with Bonitás, founders can benefit from our unmatched network and gain experience in management support. Bonitás is proud that our backed companies also propel great causes.
Show more...Investment focus
- Industry: Information Technology, Software, Education
- Stage:Seed, Series A
- Geography: Hungary
Investor stats
- Total investments: 25
- Round size: Seed $241k–$1.6M; Series A $1.1M–$4.4M
- Lead/follow: 100% lead, 0% follow
- Last fund: May invest from a new fund soon — raised $40M in 2018
Portfolio highlights
- Livlia — As Hungary’s first hybrid real estate service, portal, and ecosystem, Livlia’s goal is to revolutionize the Hungarian and the regional real estate market with their automatized working methods, modern solutions and professional real estate experts. The platform is launching today with the aim of digitalising and revolutionizing and the entire realestate industry.Ads optimization, developed price strategy, pre-identified customers, all of which can be traced on the platform which is complemented by a dedicated real estate expert. As a result of their modern and digitalised solutions and working methods, they thrive working for one of the most competitive success fees (1,5%) within the Hungarian real estate industry offering more, for less.
- MITE-CHEM KFT. — Manufacture of pesticides and other agrochemical products
- Gremon Systems — Gremon Systems Zrt. is a software and hardware development, manufacturing and sales company specialising in innovative solutions for agriculture, especially within the vegetable segment. The aim of the investment is to expand the company's existing portfolio of products and to support the entry into the dominant European and global markets.Gremon Systems provides innovative IT solutions to greenhouse growers that results in direct cost and yield benefits.
Boston Millennia Partners (BMP) has a long and successful history of growth capital investing on a national scope. Our Core Company Investment Strategy, combined with our international network of relationships and deep industry expertise, sets us apart from other investor groups and enables us to contribute meaningfully to our portfolio companies.The company focuses on investment opportunities within the healthcare and business services industries. Outsourcing and software as a service business companies are of particular interest for investment.Boston Millennia Partners' goal is to be supportive and effective investing partners, and establish productive relationships with its business partners that create long-term value.The company seeks to partner with entrepreneurs who share our goal of building enduring, large-scale businesses that result in personal fulfillment and superior financial returns. Over the past thirty years, it has implemented an investment approach that centers on active participation with our portfolio companies. Its goal is to be supportive and effective investing partners and establish productive relationships with its business partners that create long-term value.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series C, Series B
- Geography: United States, Israel, Hungary
Investor stats
- Total investments: 120
- Round size: Series B $5M–$53M; Series C $5.5M–$43M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- BEKHealth — BEKhealth's AI reads EHR data to power clinical trial recruitment, feasibility, and real-world data for sponsors, CROs, and research sites.
- Korio — Korio is an IRT platform that focuses on industry compliance.Korio integrated the most recent IRT design intelligence into our solution to address the long-standing issues of operational inefficiencies, burdensome manual processes, and poor user experiences.
- PHT Corporation — Clario, a part of Thermo Fisher Scientific, combines science-informed endpoint technology, global scale, and expert services to generate reliable clinical evidence for every trial phase.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Portfolion is a CEE-focused multi-stage investor with a flexible fund structure that allows it to back companies from or before 1st client until the end of their journey. The fund manager has backed some of the CEE region’s most successful companies including SEON, Novakid, Tresorit, Packhelp, and Starschema.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Hungary, Poland, United States
Investor stats
- Total investments: 72
- Round size: Seed $439k–$7.6M; Series A $1.6M–$13M; Series B $3.7M–$94M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $82M in 2020
Portfolio highlights
- deskbird — Most intuitive and people-centric - deskbird's hybrid workplace solution that employees will love. For all flexibe companies, from startup to corporate.
- FLOWX.AI — FLOWX.AI wraps and orchestrates legacy systems, making it incredibly easy for enterprises to create web and mobile front-ends for mission-critical business flows. The revolutionary AI-enabled Apeiron UX engine is able to automatically create a modern, intuitive front-end for customers and employees, helping to consolidate in a unified UI all thebusiness logic cross-systems.This enables companies with complex technology landscapes to create and launch mission-critical digital products fast, and then facilitate an easy path forward to full digital transformation.The revolutionary novel approach is 100x faster and cheaper than existing alternatives. FLOWX.AI allows delivery of enterprise-grade mobile and web digital front-ends as fast as 10 weeks, and requires much smaller engineering teams.
- Riptides — Riptides is the non-human identity fabric for your workloads and AI agents, and they trust Every Connection. Even the Autonomous Ones.
The official website of the European Commission, providing access to information about its political priorities, policies and services
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: France, Spain, United Kingdom
Investor stats
- Total investments: 210
- Round size: Seed $55k–$10M; Grant $117k–$36M; Pre-Seed $55k–$1.7M
- Lead/follow: 70% lead, 30% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- AFYREN — AFYREN develop innovation in biotechnologies for the valorization of non-food biomass and in respect of the environment.
- Naturbeads — Naturbeads creates biodegradable, sustainable and cost competitive cellulose microbeads to replace currently used microplastics.
- USIL Therapeutics — USIL Therapeutics is a biotechnology company focused on radiological preparedness. They develop dual-use medical countermeasures designed to protect populations and mission-critical personnel from ionizing radiation in defense, civilian, and space environments.
Széchenyi Capital Fund Management, a state-owned investment company, finances micro-, small- and medium-sized companies in Hungary.
Show more...Investment focus
- Industry: Fashion, Medical, Shopping
- Stage:Series A
- Geography: Hungary
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- AERON — ÁERON’S DESIGN IS CHARACTERIZED BY THE UNIQUE COMBINATION OF SUPERB QUALITY, INNOVATIVE CRAFTMANSHIP, AND EFFORTLESS ELEGANCE. EVERY COLLECTION FOCUSES ON REINVENTING TRADITIONAL TAILORING TECHNICS WHILEONLY USING FINEST MATERIALS SUCH AS A DISTINCTIVE SUEDE JAPANESE LEATHER THAT HAS BECOME A SIGNATURE FABRIC OF ÁERON. THE DIFFICULT BALANCE OFCREATING ONE ARTFUL PACKAGE, WHERE WORK AND PLAY HARMONIZES TOGETHER, FORMS THE MINIMAL YET FEMININE SENSUALITY OF A DECADE-DEFINING ÁERON LOOK. ÁERON ENCOMPASSES A RICH VARIETY OF HIGH-WAISTED TAILORED PANTS, ASYMMETRICAL COATS, OVERSIZE SWEATERS, AND MINIMALISTIC DRESSES.
- VRG Therapeutics — VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 133
- Round size: Seed $196k–$2M; Series A $2M–$14M
- Lead/follow: 67% lead, 33% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- 4D Medicine —
- Adludio — Adludio is the AI-powered platform that delivers interactive mobile advertising. By using data to design your ad creative, and algorithms to optimize your campaigns, Adludio makes sure you win the battle for brand attention.
- Role Mapper Technologies — Automate and transform how you design and manage job descriptions across your organisation. Hire, retain and grow an inclusive and diverse workforce with AI powered Intelligent Job Design.
Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Information Technology
- Stage:Series B, Series A
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 104
- Round size: Series A $10M–$55M; Series B $9.3M–$98M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
- Culmination Bio — Culmination Bio is a biotech company using advanced biological and clinical data to develop innovative diagnostics, therapies, and healthcare insights that improve patient outcomes.
- Strata Oncology — Learn about the latest developments in the Strata platform, including new features and updates. Explore our comprehensive range of solutions for healthcare professionals and organizations.
Early Stage Venture Investments
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Seed, Convertible Note, Series A
- Geography: United States, Canada, Hungary
Investor stats
- Total investments: 92
- Round size: Seed $105k–$3M; Series A $3M–$10M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $175k in 2021
Portfolio highlights
- Flourish Care — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
- Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
- Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series B, Series A
- Geography: France, United States, Germany
Investor stats
- Total investments: 47
- Round size: Series A $1.9M–$55M; Series B $2.1M–$15M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Netasq — Founded in 1998, Netasq is an information security company based in France. It has designed and markets Unified Threat Management solutions (hardware appliances based on a derivative of FreeBSD) which combine network and application firewall with embedded anti-virus, anti-spam, VPN and content filtering functionality with an integrated real-timeintrusion prevention technology: the ASQ (Active Security Qualification).
- Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
- METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.
We are an early-stage technology investor, managing privately financed funds. We seek to find and join the most exciting Central Eastern European teams on their global mission.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Hungary, United States, Croatia
Investor stats
- Total investments: 52
- Round size: Seed $310k–$6.5M; Pre-Seed $500k–$2.6M; Series A $2.7M–$35M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $35M in 2018
Portfolio highlights
- AERON — ÁERON’S DESIGN IS CHARACTERIZED BY THE UNIQUE COMBINATION OF SUPERB QUALITY, INNOVATIVE CRAFTMANSHIP, AND EFFORTLESS ELEGANCE. EVERY COLLECTION FOCUSES ON REINVENTING TRADITIONAL TAILORING TECHNICS WHILEONLY USING FINEST MATERIALS SUCH AS A DISTINCTIVE SUEDE JAPANESE LEATHER THAT HAS BECOME A SIGNATURE FABRIC OF ÁERON. THE DIFFICULT BALANCE OFCREATING ONE ARTFUL PACKAGE, WHERE WORK AND PLAY HARMONIZES TOGETHER, FORMS THE MINIMAL YET FEMININE SENSUALITY OF A DECADE-DEFINING ÁERON LOOK. ÁERON ENCOMPASSES A RICH VARIETY OF HIGH-WAISTED TAILORED PANTS, ASYMMETRICAL COATS, OVERSIZE SWEATERS, AND MINIMALISTIC DRESSES.
- Samebug, Inc. — Samebug is a software startup company that builds a platform to help developers to find and share solutions to software problems. Simply take a stack trace from a crash, plug it into Samebug (either via a browser or plugin to IntelliJ IDEA or Android Studio) and it will search across over a Million (and growing) solutions to determine if theproblem causing the crash has been solved by another engineer or not. If it has, Samebug will present the solution, if the problem has not been solved, Samebug will connect you with experts who can help.
- Statzup — Domain name StatZup.com is a dynamic and impactful choice for startups looking to make a bold statement in the world of statistics and data analysis. The name suggests a sense of urgency and excitement, urging users to stay on top of the la
Fast Ventures is a venture capital investment firm.
Show more...Investment focus
- Industry: Apps, Health Care, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: South Korea, Hungary, United States
Investor stats
- Total investments: 61
- Round size: Seed $111k–$2.5M; Series A $2M–$6.9M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Bind — Bind is a start-up that operates the mobile and PC version of 'Athler'.
- Doers — Doers is an influencer commerce platform that offers several services for connecting influencers and companies.
- Driving Teacher — You may search and compare the pricing of all driving schools countrywide in Driving Teacher, and you can help students make real-time training reservations with just a few clicks without connecting to a counselor. Furthermore, it provides an online reservation management platform to driving schools in order to automate the driving school system,as well as sales growth through customized marketing.
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, Singapore
Investor stats
- Total investments: 139
- Round size: Seed $2.5M–$9.3M; Series A $4.4M–$25M; Series B $7M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- SecZetta — SecZetta. We provide third-party identity risk solutions that are easy to use, and purpose built to help organizations execute risk-based identity access and lifecycle strategies for non-employee populations.
- Prove — Prove is the modern way for businesses to enable their customers to prove their identities with just a phone. Prove offers phone-centric solutions that enable its customers to acquire new consumers and engage with their existing consumers by removing friction while bolstering security, and enhancing consumer privacy and consumer choice.Prove's solutions are used by more than 1,000 businesses across diversified industries, including banks, financial services, healthcare, insurance, and e-commerce.Prove has two main solutions + MFA:• Prove Pre-fill™ for Onboarding & Digital Acquisition, which helps companies increase signups and mitigate account opening fraud by authenticating consumer identities, and auto-filling verified data in any channel.• Fonebook™ for Digital Servicing, which helps companies:- Access a single identity authentication platform that reduces complexity and total cost of ownership to create a holistic view of your customer across their entire channels - Manage, add, and update customer phone numbers to ensure you always have the right number for your customerMulti-factor Authentication:- Standard SMS & Voice OTPs - Instant Link™ (authenticate through SMS link without needing OTP) - Mobile Auth™ (authentication via cellular networks; passive method for passwordless login) - Voice Biometrics – Match against a consumer’s voice for authentication - Push Authentication – App-based method to prove Possession, can also pull in behavioral biometrics, device (PKI), and environmental (Wi-Fi, Bluetooth, network) signals - Secure transactions across multiple digital servicing use cases, including login, high-risk transactions, call center, and passwordless login
- Mine — "Mine helps you discover where your personal data is and manage your digital footprint. You decide where your data should or shouldn't be, we'll make it happen. "
Biotechnology VC funding in Hungary at a glance
Stats across 26 deals from 29 investors.
Access all 29 VC funds in Hungary Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology VC Funds in Hungary investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 29 VC funds investing in Hungary Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!